These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8247928)

  • 1. Pharmacists and the pharmaceutical industry: guidelines for ethical interactions. American College of Clinical Pharmacy.
    Pharmacotherapy; 1993; 13(5):531-3. PubMed ID: 8247928
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacists and industry: guidelines for ethical interactions.
    ; Hatton RC; Chavez ML; Jackson E; Maurey J; Barriere SL; Couchenour R; Evens RP; Gunning K; Hume AL; Hutchison LC; Matzke GR; Noviasky JA; Rospond RM; Kelloway JS; Stevenson JG; Vanderveen RP; Verme-Gibboney CN; Walters D
    Pharmacotherapy; 2008 Mar; 28(3):410-20. PubMed ID: 18294122
    [No Abstract]   [Full Text] [Related]  

  • 3. The need for ethical guidelines for relationships between pharmacists and the pharmaceutical industry.
    Zoloth AM
    Am J Hosp Pharm; 1991 Mar; 48(3):551-2. PubMed ID: 2049131
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacists' and physicians' attitudes toward pharmaceutical marketing practices.
    Poirier TI; Giannetti V; Giudici RA
    Am J Hosp Pharm; 1994 Feb; 51(3):378-81. PubMed ID: 8160692
    [No Abstract]   [Full Text] [Related]  

  • 5. Harvey A. K. Whitney lecture. Interdependence in pharmacy: risks, rewards, and responsibilities.
    Zilz DA
    Am J Hosp Pharm; 1990 Aug; 47(8):1759-65. PubMed ID: 2389781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Professional organizations and healthcare industry support: ethical conflict?
    Hazlet TK; Sullivan SD
    Camb Q Healthc Ethics; 1994; 3(2):236-44; discussion 244-56. PubMed ID: 8049771
    [No Abstract]   [Full Text] [Related]  

  • 7. Ethical attitudes of pharmacists: balancing practices and beliefs.
    Rawwas MY; Vitell SJ; Festervand TA
    Health Mark Q; 1994; 12(1):97-112. PubMed ID: 10139725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The drug industry and clinical research in interwar America: three types of physician collaborator.
    Rasmussen N
    Bull Hist Med; 2005; 79(1):50-80. PubMed ID: 15764827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing guidelines on pharmaceutical company support.
    Lane SM
    Am J Hosp Pharm; 1992 May; 49(5):1108, 1110. PubMed ID: 1595731
    [No Abstract]   [Full Text] [Related]  

  • 10. The ethics of accepting gifts from pharmaceutical companies.
    Margolis LH
    Pediatrics; 1991 Dec; 88(6):1233-7. PubMed ID: 1956742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the need for probity when physicians interact with industry.
    Scott IA
    Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Federal agency revises rule on financial disclosure by researchers.
    Maloney DM
    Hum Res Rep; 1999 Feb; 14(2):1-2. PubMed ID: 11657602
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacists should not accept gifts from industry.
    Kennelly W
    Am J Hosp Pharm; 1992 May; 49(5):1108. PubMed ID: 1595730
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical promotion and pharmacist probity.
    Zellmer WA
    Am J Hosp Pharm; 1991 Aug; 48(8):1693. PubMed ID: 1897547
    [No Abstract]   [Full Text] [Related]  

  • 15. Lets Do Lunch? The ethics of accepting gifts from the pharmaceutical industry.
    Hagen B; Pijl-Zieber EM; Souveny K; Lacroix A
    Can Nurse; 2008 Apr; 104(4):30-5. PubMed ID: 18488765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biased articles.
    Friedman JH
    Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378
    [No Abstract]   [Full Text] [Related]  

  • 17. The hidden costs of free lunches: fraud and abuse in physician-pharmaceutical arrangements.
    Gosfield AG
    J Med Pract Manage; 2005; 20(5):253-8. PubMed ID: 15921138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nurses and the pharmaceutical industry: part 2.
    Olsen DP
    Am J Nurs; 2009 Feb; 109(2):86-7. PubMed ID: 19300016
    [No Abstract]   [Full Text] [Related]  

  • 19. ASHP guidelines for pharmacists on the activities of vendors' representatives in organized health care systems. American Society of Hospital Pharmacists.
    Meyer GE; Keith TD; Gutfeld MB; Johnson D
    Am J Hosp Pharm; 1994 Feb; 51(4):520-1. PubMed ID: 8017422
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines for relationships between industry and the American College of Obstetricians and Gynecologists and its fellows. ACOG Committee Opinion No. 45.
    American College of Obstetricians and Gynecologists [ACOG]. Committee on Ethics
    ACOG Comm Opin; 1985 Oct; No. 45():1 p. PubMed ID: 11660326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.